VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,118 | +2.6% | 41,468 | +12.2% | 0.02% | -4.0% |
Q2 2023 | $1,090 | -8.6% | 36,968 | 0.0% | 0.02% | -3.8% |
Q1 2023 | $1,193 | +11.0% | 36,968 | -1.2% | 0.03% | +8.3% |
Q4 2022 | $1,075 | -99.9% | 37,418 | -5.7% | 0.02% | +14.3% |
Q3 2022 | $940,000 | +522.5% | 39,689 | +627.0% | 0.02% | +600.0% |
Q2 2022 | $151,000 | -78.7% | 5,459 | -70.3% | 0.00% | -75.0% |
Q1 2022 | $710,000 | +187.4% | 18,374 | +137.6% | 0.01% | +500.0% |
Q4 2021 | $247,000 | -78.4% | 7,734 | -80.1% | 0.00% | -83.3% |
Q3 2021 | $1,144,000 | -22.0% | 38,803 | -10.1% | 0.01% | -20.0% |
Q2 2021 | $1,466,000 | +18225.0% | 43,156 | +18501.7% | 0.02% | – |
Q1 2021 | $8,000 | -63.6% | 232 | -61.3% | 0.00% | – |
Q4 2020 | $22,000 | -8.3% | 600 | 0.0% | 0.00% | – |
Q3 2020 | $24,000 | -95.3% | 600 | -97.3% | 0.00% | -100.0% |
Q4 2017 | $508,000 | +3.7% | 21,866 | -0.6% | 0.01% | +8.3% |
Q3 2017 | $490,000 | +84.2% | 22,000 | +85.4% | 0.01% | +100.0% |
Q2 2017 | $266,000 | -2.2% | 11,866 | 0.0% | 0.01% | -14.3% |
Q1 2017 | $272,000 | +13.3% | 11,866 | 0.0% | 0.01% | +16.7% |
Q4 2016 | $240,000 | -91.5% | 11,866 | -88.8% | 0.01% | -92.6% |
Q3 2016 | $2,812,000 | -31.9% | 106,400 | -28.6% | 0.08% | -28.9% |
Q2 2016 | $4,129,000 | – | 149,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
Brown University | 541,096 | $19,490,000 | 14.10% |
Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |